29例中晚期前列腺癌的综合治疗疗效分析  

The Clinical Analysis for 29 Cases Late Advanced Prostate Carcinoma

作　　者：李智军[1] 刘阿秋[1] 屠波[1] 郑利枝[1] 刘伟[1] 贾明[1] 

机构地区：[1]内蒙古自治区医院放疗科,内蒙古呼和浩特010017

出　　处：《内蒙古医学杂志》2009年第2期160-161,共2页Inner Mongolia Medical Journal

摘　　要：目的:探讨以内分泌治疗为主辅以放疗的综合治疗中晚期前列腺癌的临床疗效。方法:采用内分泌治疗(双侧睾丸切除术及术后口服康士得)为主,辅以前列腺局部放疗的综合治疗29例中晚期前列腺癌,随访症状改善情况、血PSA值及生存时间。结果:下尿路梗阻症状改善率92%(23/25)和转移性骨痛症状改善率86.7%(13/15),血PSA下降率92.3%(24/26)。结论:内分泌治疗为主,辅以前列腺局部放疗的综合治疗是中晚期前列腺癌治疗的主要治疗方法,可明显改善症状,控制疾病进展,延长生存时间。Objective：To investigate the efficacy of combined therapy in the treatment of ladvanced prostatic cancer. Method： 29 patients with late - advanced prostatic cancer were received combined therapy which included bilateral testectomy, endocrine therapy and radiation therapy. The clinical symplom and the prostate specific antigen（PSA） level were followed up. The survival time was recorded. Result： The symptoms improvement rate of 92 % （23/25）, urethral obstruction and metastatic bone pains symetom improvement rate of 86.7 % （13/15）. The serum PSA were significant reduced. Conclusion：The combined therapy with endocrine therapy is the major treatment for ladvanced prostatic cancer. It can ease the symptoms, control the disease and lengthen the survival time.

关 键 词：前列腺癌 内分泌治疗 放射治疗 

分 类 号：R737.25[医药卫生—肿瘤]